“…In vitro assays showed that OSW-1 was extremely toxic against a broad spectrum of malignant tumor cells, such as leukemia HL-60, mouse mastrocarcinoma, human pulmonary adenocarcinoma, human pulmonary large cell carcinoma, and human pulmonary squamous cell carcinoma including adriamycin-resistant P388 leukemia and camptothecin-resistant P388, with IC50 between 0.1 and 0.7 nM, which is about 10-100 times more potent than those of the clinically applied anticancer agents, such as mitomycin C, adriamycin, cisplatin, camptothecin and taxol. 65 The cytotoxicity profile of OSW-1 is strikingly similar to that of cephalostatins, a group of dimeric steroidpyrazines from marine organisms, 67 with Pearson correlation coefficients between 0.60 and 0.83, 65 while structurally, the aglycone of OSW-1 is reminiscent of half of the cephalostatins. Fuchs therefore hypothesized that they might have the same mechanism of action.…”